Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Virtual Agent Feasibility in Oncology Patients (NTT Data)

NCT: NCT06682013 · WITHDRAWN

NCT IDNCT06682013
StatusWITHDRAWN
Start Date2026-05
Completion2026-05

Brief Summary

The purpose of this study is to compare the use of a virtual agent vs. a human agent when onboarding oncology patients over the telephone to Remote Patient Monitoring (RPM) devices. RPM devices are instruments that a patient can use to measure their own weight and vital signs. Both the virtual and human agents will be available by telephone to instruct the patient on how to use the RPM devices to measure weight, blood pressure, heart rate, temperature, and oxygen saturation. Patients will be randomized to either the virtual or human agent, have assessments of their medical and oncological history, overall well-being, body measurements, and vital signs, and will complete questionnaires about their experience.

Frequently Asked Questions

What is Virtual Agent Feasibility in Oncology Patients (NTT Data)?

Virtual Agent Feasibility in Oncology Patients (NTT Data) is a clinical trial registered under NCT06682013. Current status: WITHDRAWN.

What is the status of NCT06682013?

The current status of NCT06682013 (Virtual Agent Feasibility in Oncology Patients (NTT Data)) is: WITHDRAWN.

When did Virtual Agent Feasibility in Oncology Patients (NTT Data) start?

Virtual Agent Feasibility in Oncology Patients (NTT Data) started on 2026-05.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.